MicroRNA-30b inhibits non-small cell lung cancer cell growth by targeting the epidermal growth factor receptor

Z. QI, B. ZHANG, J. ZHANG, Q. HU, F. XU, B. CHEN, C. ZHU
2018 Neoplasma (Bratislava)  
Lung cancer, especially non-small cell lung cancer (NSCLC), is the leading cause of cancer-related mortality in the world. Both microRNAs and epidermal growth factor receptor (EGFR) are important factors in NSCLC. In our study, the expression of miR-30b in 47 tumor tissues and paired normal tissues of NSCLC were detected by RT-PCR, and we found that miR-30b was down-regulated in NSCLC tumor tissues and was associated with TNM stage, diff erentiation, and lymph node metastases. Th en we
more » ... ted the ability of miR-30b to regulate EGFR in several NSCLC cell lines, and found that miR-30b inhibited proliferation, migration and invasion, induced apoptosis and enhanced sensitivity of the NSCLC cells to EGFR tyrosine kinase inhibitors (EGFR-TKIs) by targeting EGFR and repressing EGFR signaling pathways. Overall, these results indicate that miR-30b may be a potential therapeutic target in NSCLC patients.
doi:10.4149/neo_2018_170217n118 pmid:29534579 fatcat:euymyrhevjhgza4meligfr3n2y